Digital Chatbot for Eating Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a digital chatbot program designed to assist individuals with eating disorders. It explores various approaches to aid emotional regulation, resist binge urges, manage dietary restraint, and address concerns about weight and shape. Participants are divided into groups to test different chatbot features. This study is suitable for U.S. residents who have a smartphone, speak English, and have an eating disorder diagnosis but are not currently receiving treatment. As a Phase 2 trial, the research measures the treatment's effectiveness in an initial, smaller group, offering participants the opportunity to contribute to the development of innovative support tools.
Will I have to stop taking my current medications?
If you are taking medications that affect your appetite or weight, you may not be eligible for this trial. The protocol does not specify if you need to stop other medications.
What prior data suggests that this digital chatbot program is safe for adults with eating disorders?
Research has shown that digital chatbots are generally safe for use, particularly in mental health care. A study on chatbots for eating disorders aims to enhance their effectiveness in managing emotions, controlling diet, and addressing body image concerns. As a Phase 2 trial, the chatbot has already undergone safety testing in smaller groups. This phase emphasizes effectiveness rather than identifying new safety issues. Chatbots are typically well-received, with few reported problems. They are designed to offer support and guidance, making them a low-risk option for those considering trial participation.12345
Why are researchers excited about this trial's treatments?
Researchers are excited about these digital chatbot programs for eating disorders because they offer a unique, tech-based approach to addressing key aspects of the condition. Unlike traditional therapy that often requires in-person sessions, these chatbots provide 24/7 access, allowing participants to work on emotion regulation, dietary restraint, and resisting urges to binge whenever they need. This immediate accessibility and personalized practice could lead to more consistent engagement and potentially faster improvements. Additionally, the chatbot's ability to target specific components like weight and shape over-evaluation offers a tailored experience that can adapt to individual needs, setting it apart from more generalized treatment options.
What evidence suggests that this trial's digital chatbot program could be effective for eating disorders?
Studies have shown that digital chatbots can effectively help with eating disorder symptoms. In this trial, participants will engage with different chatbot components targeting specific challenges such as controlling emotions, resisting the urge to binge eat, and maintaining healthy eating habits. Research indicates that these chatbots assist users in managing these challenges. Users have reported feeling better about their eating-related thoughts and behaviors after using these tools. Initial findings suggest that the chatbot's ability to offer immediate support and practice exercises helps manage eating disorder symptoms. Additionally, these chatbots provide a convenient and accessible way for people to engage with treatment whenever it suits them.13467
Who Is on the Research Team?
Ellen Fitzsimmons-Craft, Ph.D.
Principal Investigator
Washington University School of Medicine
Are You a Good Fit for This Trial?
Adults over 18 living in the US with clinical or subclinical eating disorders can join this trial if they own a smartphone, speak English, and are not at high risk of suicide. They shouldn't be pregnant, in current treatment for an eating disorder, or have conditions/medications affecting appetite/weight.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive access to various chatbot components targeting different aspects of eating disorders, such as emotion dysregulation, dietary restraint, and resisting urges to binge.
Treatment
Participants receive access to various chatbot components targeting different aspects of eating disorders, such as emotion dysregulation, dietary restraint, and resisting urges to binge.
Follow-up
Participants are monitored for changes in ED psychopathology, ED behavior frequencies, comorbid symptoms, and clinical impairment.
Follow-up
Participants are monitored for changes in ED psychopathology, ED behavior frequencies, comorbid symptoms, and clinical impairment.
What Are the Treatments Tested in This Trial?
Interventions
- Digital Chatbot Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor
New York University
Collaborator
University of South Carolina
Collaborator